Abstract:Population-scale resources of genetic, molecular, and cellular information form the basis for understanding human genomes, charting the heritable basis of disease, and tracing the effects of mutations. Pooled perturbation assays applied to cellular models, probing the effect of many perturbations coupled with an scRNA-seq readout (Perturb-seq), are especially potent references for interpreting disease-linked mutations or gene expression changes. However, the utility of existing maps has been limited by the comprehensiveness of perturbations possible, and the relevance of their cell line context. Here, we present the first genome-scale CRISPR interference (CRISPRi) perturbation map with single-cell RNA sequencing readout across many human genetic backgrounds in human pluripotent cells. To do so, we establish large-scale CRISPRi screening in human induced pluripotent stem cells from healthy donors, using over 20,000 guide RNAs to target 7,226 genes across 34 cell lines from 26 genetic backgrounds, and gather expression data from nearly 2 million cells. We comprehensively map trans expression changes induced by the target knockdowns, which complement co-expression patterns in unperturbed cells and facilitate the functional annotation of target genes to biological processes and complexes. Consistency of targeting protein complex members point to protein complexes as a nexus for aggregating transcriptional variation, revealing novel interaction partners. We characterise variation in perturbation effects across donors, with expression quantitative trait loci linked to higher genetic modulation of perturbation effects but overall low replication of trans effects due to knockdown of their corresponding cis regulators. This study pioneers population-scale CRISPR perturbations with single cell readouts that will fuel foundation models for the future of effective modulation of cellular disease phenotypes.

CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons

CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions

A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity

Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures

CRISPRi: a way to integrate iPSC-derived neuronal models

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

Drug screening for human genetic diseases using iPSC models

Genetic and Pharmacological Interrogation of Cancer Vulnerability Using a Multiplexed Cell Line Screening Platform

A genome-scale single cell CRISPRi map of trans gene regulation across human pluripotent stem cell lines

Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons

Dual genome-wide coding and lncRNA screens in neural induction of induced pluripotent stem cells

Functional Screening Assays with Neurons Generated from Pluripotent Stem Cell–Derived Neural Stem Cells

CRISPRi with barcoded expression reporters dissects regulatory networks in human cells

High-throughput CRISPRi and CRISPRa technologies in 3D genome regulation for neuropsychiatric diseases

Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements

An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression

A Cre-Dependent CRISPR/dCas9 System for Gene Expression Regulation in Neurons

High-content imaging-based pooled CRISPR screens in mammalian cells

Unlocking biological mechanisms with integrative functional genomics approaches

Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution

aiCRISPRL: An Artificial Intelligence Platform for Stem Cell and Organoid Simulation with Extensive Gene Editing Capabilities